Search Within

Weinberg Fellows

Formats
  1. Meeting Abstract (1256)
  2. Journal Article (1048)
  3. Review (106)
  4. Editorial (54)
  5. Research Letter (31)
  6. Book Section (22)
  7. Correspondence (20)
  8. Guidelines (11)
  9. Conference Paper (2)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (2457)
  2. Solid Tumor Oncology Division (1873)
  3. Hematologic Malignancies, Division of (1185)
  4. GSK Faculty (1120)
  5. Department of Pathology and Laboratory Medicine (914)
  6. Epidemiology and Biostatistics (859)

More Groups

People
  1. Michael Berger (215)
  2. Marc Ladanyi (191)
  3. Pedram Razavi (184)
  4. Michael Offin (172)
  5. David Solit (166)
  6. Maria Carlo (165)

More People

Years
  1. 2025 (136)
  2. 2024 (370)
  3. 2023 (292)
  4. 2022 (347)
  5. 2021 (307)
  6. 2020 (307)

More Years

Publications
  1. Journal of Clinical Oncology (545)
  2. Blood (248)
  3. Annals of Oncology (98)
  4. Clinical Cancer Research (95)
  5. Journal of Thoracic Oncology (81)
  6. Cancer Research (80)

More Publications

Publishers
  1. American Society of Clinical Oncology (614)
  2. Elsevier Inc. (353)
  3. American Society of Hematology (282)
  4. American Association for Cancer Research (217)
  5. Nature Publishing Group (175)
  6. Oxford University Press (147)

More Publishers

Results (2551)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world risk of recurrence and treatment outcomes with adjuvant endocrine therapy in patients with stage II-III HR+/HER2- early breast cancer
    Journal Article

    O'Shaughnessy, J.; Tolaney, S. M.; Yardley, D. A.; Hart, L.; Razavi, P.; Fasching, P. A.; Janni, W.; Schwartzberg, L.; Kim, J.; Akdere, M.; more...
    Breast (2025)

    Fulltext@MSK | Save
  • Enhancing the persistence and anti-tumor efficacy of CAR-T and CAR-NK cells through genetic disruption of death receptors
    Meeting Abstract

    Cohen, T. D.; Yi, F.; Zumbo, P.; Etilib, R.; Arkin, H.; Gormally, M.; Hackett, C. S.; Kropp, K.; Etxeberria, I.; Chandran, S. S.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Clinical and genomic characterization of a single-center cohort of renal cell carcinoma patients with KRAS mutation
    Meeting Abstract

    Sanmiguel, A. L.; Hakimi, A. A.; Khandwala, Y.; Calderon, L. P.; Dawidek, M.; Chen, Y. B.; Russo, P.; Coleman, J.; Carlo, M.
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Correlative science from a phase I study of intravesical Fc-optimized anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guerin (BCG)
    Meeting Abstract

    Bochner, B. H.; Alam, S. M.; Blanchard, L.; Yao, N.; Angulo-Lozano, J.; Wong, J.; Knorr, D.; Whiting, K.; Seshan, V.; Donahue, T.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade
    Journal Article

    Babatunde, O. O.; Membribes, S. C.; Anthonescu, C.; Bradic, M.; O'Malley, B.; Linkov, I.; Bartlett, E.; Momtaz, P.; Alektiar, K.; Gounder, M. M.; more...
    npj Precision Oncology (2025)

    Fulltext@MSK | Save
  • Multi-institutional analysis of immune-oncology combination therapy for metastatic MiT family translocation renal cell carcinoma
    Journal Article

    Ged, Y.; Touma, A.; Contreras, L. M.; Elias, R.; Van Galen, J.; Cupo, O.; Baraban, E.; Singla, N.; Lee, C. H.; Pal, S.; more...
    Journal of Immunotherapy (2025)

    Fulltext@MSK | Save
  • Guide to understanding and supporting international medical graduates in hematology/oncology by the ASCO International Medical Graduates Community of Practice
    Review

    Dizman, N.; Bakouny, Z.; Haykal, T.; Riano, I.; Desai, A.; Butt, A.; Basu, A.; Zhao, D.; Saad, E.; Saliby, R. M.; more...
    JCO Oncology Practice (2025)

    Fulltext@MSK | Save
  • Intracranial outcomes of ipilimumab and nivolumab in melanoma brain metastases after progression on anti-PD-1 therapy
    Research Letter

    Lochrin, S. E.; Kalvin, H. L.; Smithy, J. W.; Chen, M. F.; Momtaz, P.; Shoushtari, A. N.; Panageas, K. S.; Postow, M. A.
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Clinical outcomes and targeted genomic analysis of renal cell carcinoma brain metastases treated with stereotactic radiosurgery
    Journal Article

    Ma, J.; del Balzo, L.; Walch, H.; Khaleel, S.; Knezevic, A.; Flynn, J.; Zhang, Z.; Eichholz, J.; Doshi, S. D.; Voss, M. H.; more...
    European Urology Oncology (2025)

    Fulltext@MSK | Save
  • Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors
    Journal Article

    Khaleel, S.; Perera, M.; Papa, N.; Kuo, F.; Golkaram, M.; Rappold, P.; Kotecha, R. R.; Coleman, J.; Russo, P.; Motzer, R.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save